reports
Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and O...
Evidence of Efficacy and Safety of Deucrictibant for Prophylaxis and On-Demand Treatment of Hereditary Angioedema Attacks Published Back-to-Back in The Lancet Haematology Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management of HAE ZUG, Switzerland, March 20, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioede...
- Jerôme Bodin
AC ACCOR SA
FRA FRAPORT AG
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
WTB WHITBREAD PLC
IDL ID LOGISTICS GROUP
STF STEF
DEC JCDECAUX SA
VIV VIVENDI SE
SWP SWORD GROUP SE
GBT GUERBET SA
ACX ACERINOX SA
ENI ENI S.P.A.
NEX NEXANS SA
REP REPSOL SA
ERG ERG S.P.A.
MLP MLP SE
KOMN KOMAX HOLDING AG
SEFER SERGEFERRARI GROUP SA
SHOT SCANDIC HOTELS GROUP
WAF SILTRONIC AG
WBD WEBUILD S.P.A.
TWEKA TKH GROUP N.V. CERT
LTA ALTAMIR ACT PORTEUR
INSD VERIMATRIX SA
SIFG SIF HOLDING NV
VLTSA VOLTALIA
MEL MELIA HOTELS INTERNATIONAL S.A.
NHH NH HOTEL GROUP SA
MAU ETABLISSEMENTS MAUREL & PROM SA
BP. BP P.L.C.
IHG INTERCONTINENTAL HOTELS GROUP PLC
SHEL SHELL PLC
- Jerôme Bodin
AC ACCOR SA
FRA FRAPORT AG
EQNR EQUINOR ASA
GALP GALP ENERGIA SGPS SA CLASS B
WTB WHITBREAD PLC
IDL ID LOGISTICS GROUP
STF STEF
DEC JCDECAUX SA
VIV VIVENDI SE
SWP SWORD GROUP SE
GBT GUERBET SA
ACX ACERINOX SA
ENI ENI S.P.A.
NEX NEXANS SA
REP REPSOL SA
ERG ERG S.P.A.
MLP MLP SE
KOMN KOMAX HOLDING AG
SEFER SERGEFERRARI GROUP SA
SHOT SCANDIC HOTELS GROUP
WAF SILTRONIC AG
WBD WEBUILD S.P.A.
TWEKA TKH GROUP N.V. CERT
LTA ALTAMIR ACT PORTEUR
INSD VERIMATRIX SA
SIFG SIF HOLDING NV
VLTSA VOLTALIA
MEL MELIA HOTELS INTERNATIONAL S.A.
NHH NH HOTEL GROUP SA
MAU ETABLISSEMENTS MAUREL & PROM SA
BP. BP P.L.C.
IHG INTERCONTINENTAL HOTELS GROUP PLC
SHEL SHELL PLC
- Martijn Den Drijver
Validation of Patient-Reported Outcomes in the On-Demand Treatment of ...
Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology Data include a concurrent assessment of results collected from PGI and AMRA instruments, insights into clinically meaningful changes in HAE attack symptoms, and support for hierarchical ranking of RAPIDe-3 endpoints ZUG, Switzerland, March 11, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykin...
- Baptiste Salaville
- Julian Dobrovolschi
IPS IPSOS
SCHP SECHE ENVIRONNEMENT
LOGN LOGITECH INTERNATIONAL S.A.
FP TOTAL SE
ENX EURONEXT NV
VIE VEOLIA ENVIRONNEMENT SA
EDEN EDENRED SA
EQNR EQUINOR ASA
ETL EUTELSAT COMMUNICATIONS SA
ENGI ENGIE SA.
EDP EDP-ENERGIAS DE PORTUGAL SA
SESGL SES SA FDR (CLASS A)
GALP GALP ENERGIA SGPS SA CLASS B
FORTUM FORTUM OYJ
TFI TELEVISION FRANCAISE 1 SA
DBG DERICHEBOURG SA
ELG ELMOS SEMICONDUCTOR SE
EOAN E.ON SE
BOSS HUGO BOSS AG
REE RED ELECTRICA CORP. SA
ENI ENI S.P.A.
ELE ENDESA S.A.
ORSTED ORSTED
RWE RWE AG
VER VERBUND AG CLASS A
ENEL ENEL SPA
WPP WPP PLC
REP REPSOL SA
SOI SOITEC SA
ERG ERG S.P.A.
AIXA AIXTRON SE
GAS NATURGY ENERGY GROUP S.A.
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
KOMN KOMAX HOLDING AG
ELI ELIA GROUP SA/NV
SESL SES-IMAGOTAG SA
EDW EDP RENOVAVEIS SA
SAX STROEER SE & CO. KGAA
SSO SCATEC ASA
MELE MELEXIS NV
ENG ENAGAS SA
TIT TELECOM ITALIA S.P.A.
TWEKA TKH GROUP N.V. CERT
RENE REDES ENERGETICAS NACIONAIS SA
IBE IBERDROLA SA
VLTSA VOLTALIA
MOB MOBILEZONE HOLDING AG
FNTN FREENET AG
SLR SOLARIA ENERGIA Y MEDIO AMBIENTE S.A.
IDR INDRA SISTEMAS S.A. CLASS A
COPN COSMO PHARMACEUTICALS NV
BP. BP P.L.C.
BFSA BEFESA SA
REY REPLY S.P.A.
STM STMICROELECTRONICS NV
DMP DERMAPHARM HOLDING SE
M MED LIFE
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
WAVE WAVESTONE SA
GRE GRENERGY RENOVABLES
NEXI NEXI S.P.A.
DSC1 DUTCH STAR C SHAR
BAR BARCO NV
AG1 AUTO1 GROUP
NA9 NAGARRO
ANE CORPORACION ACCIONA ENERGIAS RENOVABLES SA
DSY DASSAULT SYSTEMES SA
OVH OVH GROUPE
SHEL SHELL PLC
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
ARM ARM HOLDINGS PLC
UN0 UNIPER SE
EXENS EXOSENS
AMS AMS-OSRAM AG
SPG SPRINGER NATURE AG & CO. KGAA
ALHG LOUIS HACHETTE GROUP
- Baptiste Salaville
- Julian Dobrovolschi
IPS IPSOS
SCHP SECHE ENVIRONNEMENT
LOGN LOGITECH INTERNATIONAL S.A.
FP TOTAL SE
ENX EURONEXT NV
VIE VEOLIA ENVIRONNEMENT SA
EDEN EDENRED SA
EQNR EQUINOR ASA
ETL EUTELSAT COMMUNICATIONS SA
ENGI ENGIE SA.
EDP EDP-ENERGIAS DE PORTUGAL SA
SESGL SES SA FDR (CLASS A)
GALP GALP ENERGIA SGPS SA CLASS B
FORTUM FORTUM OYJ
TFI TELEVISION FRANCAISE 1 SA
DBG DERICHEBOURG SA
ELG ELMOS SEMICONDUCTOR SE
EOAN E.ON SE
BOSS HUGO BOSS AG
REE RED ELECTRICA CORP. SA
ENI ENI S.P.A.
ELE ENDESA S.A.
ORSTED ORSTED
RWE RWE AG
VER VERBUND AG CLASS A
ENEL ENEL SPA
WPP WPP PLC
REP REPSOL SA
SOI SOITEC SA
ERG ERG S.P.A.
AIXA AIXTRON SE
GAS NATURGY ENERGY GROUP S.A.
ATS AT & S AUSTRIA TECHNOLOGIE & SYSTEMTECHNIK AKTIENGESELLSCHAFT
KOMN KOMAX HOLDING AG
ELI ELIA GROUP SA/NV
SESL SES-IMAGOTAG SA
EDW EDP RENOVAVEIS SA
SAX STROEER SE & CO. KGAA
SSO SCATEC ASA
MELE MELEXIS NV
ENG ENAGAS SA
TIT TELECOM ITALIA S.P.A.
TWEKA TKH GROUP N.V. CERT
RENE REDES ENERGETICAS NACIONAIS SA
IBE IBERDROLA SA
VLTSA VOLTALIA
MOB MOBILEZONE HOLDING AG
FNTN FREENET AG
SLR SOLARIA ENERGIA Y MEDIO AMBIENTE S.A.
IDR INDRA SISTEMAS S.A. CLASS A
COPN COSMO PHARMACEUTICALS NV
BP. BP P.L.C.
BFSA BEFESA SA
REY REPLY S.P.A.
STM STMICROELECTRONICS NV
DMP DERMAPHARM HOLDING SE
M MED LIFE
BESI BE SEMICONDUCTOR INDUSTRIES N.V.
WAVE WAVESTONE SA
GRE GRENERGY RENOVABLES
NEXI NEXI S.P.A.
DSC1 DUTCH STAR C SHAR
BAR BARCO NV
AG1 AUTO1 GROUP
NA9 NAGARRO
ANE CORPORACION ACCIONA ENERGIAS RENOVABLES SA
DSY DASSAULT SYSTEMES SA
OVH OVH GROUPE
SHEL SHELL PLC
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
ARM ARM HOLDINGS PLC
UN0 UNIPER SE
EXENS EXOSENS
AMS AMS-OSRAM AG
SPG SPRINGER NATURE AG & CO. KGAA
ALHG LOUIS HACHETTE GROUP
- Martijn Den Drijver
- Bruno Cavalier
- Jerôme Bodin
LOGN LOGITECH INTERNATIONAL S.A.
FP TOTAL SE
ENX EURONEXT NV
EQNR EQUINOR ASA
ETL EUTELSAT COMMUNICATIONS SA
GALP GALP ENERGIA SGPS SA CLASS B
SLB.N SCHLUMBERGER NV
MC LVMH MOET HENNESSY LOUIS VUITTON SE
BFIT BASIC-FIT NV
GTT GAZTRANSPORT & TECHNIGAZ SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
SBMO SBM OFFSHORE NV
TFI TELEVISION FRANCAISE 1 SA
ZVTG ZAVAROVALNICA TRIGLAV D.D.
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
ELG ELMOS SEMICONDUCTOR SE
ENI ENI S.P.A.
COTN COMET HOLDING AG
CICN CICOREL HOLDING S.A.
WPP WPP PLC
P2F PETROFAC LIMITED
01913 PRADA S.P.A.
REP REPSOL SA
SAVE SAVENCIA SA
TUB TUBACEX S.A.
SOC SUBSEA 7 S.A.
AIXA AIXTRON SE
ROYAL VOPAK NV
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
SESL SES-IMAGOTAG SA
SAX STROEER SE & CO. KGAA
MONC MONCLER SPA
BCHN BURCKHARDT COMPRESSION HOLDING AG
TWEKA TKH GROUP N.V. CERT
POSR POZAVAROVALNICA SAVA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
BOSN BOSSARD HOLDING AG
SFSN SFS GROUP AG
TRE TECNICAS REUNIDAS SA
COPN COSMO PHARMACEUTICALS NV
TEC TECHNIPFMC PLC
BP. BP P.L.C.
NKT NKT A/S
STM STMICROELECTRONICS NV
NEXI NEXI S.P.A.
DSC1 DUTCH STAR C SHAR
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
ZGN ERMENEGILDO ZEGNA NV
SHEL SHELL PLC
DEME DEME GROUP NV
SPM SAIPEM S.P.A.
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
TEN TENARIS S.A.
VIRI VIRIDIEN
AMS AMS-OSRAM AG
ATO ATOS SE
- Bruno Cavalier
- Jerôme Bodin
LOGN LOGITECH INTERNATIONAL S.A.
FP TOTAL SE
ENX EURONEXT NV
EQNR EQUINOR ASA
ETL EUTELSAT COMMUNICATIONS SA
GALP GALP ENERGIA SGPS SA CLASS B
SLB.N SCHLUMBERGER NV
MC LVMH MOET HENNESSY LOUIS VUITTON SE
BFIT BASIC-FIT NV
GTT GAZTRANSPORT & TECHNIGAZ SA
UHR SWATCH GROUP LTD. BEARER
RMS HERMES INTERNATIONAL SCA
SBMO SBM OFFSHORE NV
TFI TELEVISION FRANCAISE 1 SA
ZVTG ZAVAROVALNICA TRIGLAV D.D.
EL ESSILORLUXOTTICA SA
BRBY BURBERRY GROUP PLC
KER KERING SA
ELG ELMOS SEMICONDUCTOR SE
ENI ENI S.P.A.
COTN COMET HOLDING AG
CICN CICOREL HOLDING S.A.
WPP WPP PLC
P2F PETROFAC LIMITED
01913 PRADA S.P.A.
REP REPSOL SA
SAVE SAVENCIA SA
TUB TUBACEX S.A.
SOC SUBSEA 7 S.A.
AIXA AIXTRON SE
ROYAL VOPAK NV
SBO SCHOELLER-BLECKMANN OILFIELD EQUIPMENT AG
SESL SES-IMAGOTAG SA
SAX STROEER SE & CO. KGAA
MONC MONCLER SPA
BCHN BURCKHARDT COMPRESSION HOLDING AG
TWEKA TKH GROUP N.V. CERT
POSR POZAVAROVALNICA SAVA
BC BRUNELLO CUCINELLI S.P.A.
CFR COMPAGNIE FINANCIERE RICHEMONT SA
BOSN BOSSARD HOLDING AG
SFSN SFS GROUP AG
TRE TECNICAS REUNIDAS SA
COPN COSMO PHARMACEUTICALS NV
TEC TECHNIPFMC PLC
BP. BP P.L.C.
NKT NKT A/S
STM STMICROELECTRONICS NV
NEXI NEXI S.P.A.
DSC1 DUTCH STAR C SHAR
VK VALLOUREC SA
TE TECHNIP ENERGIES NV
ZGN ERMENEGILDO ZEGNA NV
SHEL SHELL PLC
DEME DEME GROUP NV
SPM SAIPEM S.P.A.
FLE PEGASUS ENTREPRENEURIAL ACQUISITION CO EURO BV
TEN TENARIS S.A.
VIRI VIRIDIEN
AMS AMS-OSRAM AG
ATO ATOS SE
- Martijn Den Drijver
- Anthony Dick
- Michael Foundoukidis
- Thomas Zlowodzki
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
RNO RENAULT SA
VOLV B VOLVO AB CLASS B
EO FAURECIA SA
DAI DAIMLER AG
GBF BILFINGER SE
POM PLASTIC OMNIUM SE
SCR SCOR SE
TYRES NOKIAN RENKAAT OYJ
GLO GL EVENTS SA
FR VALEO SE
CICN CICOREL HOLDING S.A.
VOW3 VOLKSWAGEN AG PREF
IMPN IMPLENIA AG
POS PORR AG
SIX2 SIXT SE
SEM SEMPERIT HOLDING AG
PAT PATRIZIA AG
CIE CIE AUTOMOTIVE S.A.
SAX STROEER SE & CO. KGAA
ZAG ZUMTOBEL GROUP AG
TWEKA TKH GROUP N.V. CERT
FLU FLUGHAFEN WIEN AG
BOSN BOSSARD HOLDING AG
WPL WIRTUALNA POLSKA HOLDING SA
RACE FERRARI NV
DUE DURR AG
PIRC PIRELLI & C. S.P.A.
GEST GESTAMP AUTOMOCION S.A.
CENER CENERGY
8TRA TRATON SE
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
STLA STELLANTIS N.V.
DTG DAIMLER TRUCK
IVG IVECO GROUP
CABKA CABKA N.V.
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
VT5 VT5 ACQUISITION COMPANY AG
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
R3NK RENK GROUP AG
ALIV SDB AUTOLIV INC.
BRE BREMBO S.P.A.
FERGR FERRARI GROUP PUBLIC LIMITED COMPANY
- Anthony Dick
- Michael Foundoukidis
- Thomas Zlowodzki
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
RNO RENAULT SA
VOLV B VOLVO AB CLASS B
EO FAURECIA SA
DAI DAIMLER AG
GBF BILFINGER SE
POM PLASTIC OMNIUM SE
SCR SCOR SE
TYRES NOKIAN RENKAAT OYJ
GLO GL EVENTS SA
FR VALEO SE
CICN CICOREL HOLDING S.A.
VOW3 VOLKSWAGEN AG PREF
IMPN IMPLENIA AG
POS PORR AG
SIX2 SIXT SE
SEM SEMPERIT HOLDING AG
PAT PATRIZIA AG
CIE CIE AUTOMOTIVE S.A.
SAX STROEER SE & CO. KGAA
ZAG ZUMTOBEL GROUP AG
TWEKA TKH GROUP N.V. CERT
FLU FLUGHAFEN WIEN AG
BOSN BOSSARD HOLDING AG
WPL WIRTUALNA POLSKA HOLDING SA
RACE FERRARI NV
DUE DURR AG
PIRC PIRELLI & C. S.P.A.
GEST GESTAMP AUTOMOCION S.A.
CENER CENERGY
8TRA TRATON SE
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
STLA STELLANTIS N.V.
DTG DAIMLER TRUCK
IVG IVECO GROUP
CABKA CABKA N.V.
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
VT5 VT5 ACQUISITION COMPANY AG
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
R3NK RENK GROUP AG
ALIV SDB AUTOLIV INC.
BRE BREMBO S.P.A.
FERGR FERRARI GROUP PUBLIC LIMITED COMPANY
- ING Helpdesk
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Livio Luyten
- Lynn Hautekeete
- Thibault Leneeuw
- Wim Hoste
- Wim Lewi
- Martijn Den Drijver
- Jacob Mekhael
- Livio Luyten
- Lynn Hautekeete
- Wim Hoste
- Jacob Mekhael
Pharvaris Presents supportive data for deucrictibant in HAE at AAAAI
Pharvaris presented multiple datasets for deucrictibant in HAE patients in both the on-demand and prophylactic settings at the AAAAI conference. While acknowledging the usual caveats of cross-trial comparison, we believe the data gives deucrictibant a slight edge over Ekterly in the on-demand setting, where a larger proportion of deucrictibant-treated patients achieved onset of symptom relief within 12 hours (90% vs. 76% with Ekterly). In the phase 2 OLE in the prophylactic setting, long term ou...
Deucrictibant Data Supporting Potentially Differentiated Profile for t...
Deucrictibant Data Supporting Potentially Differentiated Profile for the On-Demand and Prophylactic Treatment of Bradykinin-Mediated Angioedema Presented at AAAAI 2026 RAPIDe-3 met the primary and all 11 secondary efficacy endpoints with high statistical significance with deucrictibant achieving onset of symptom relief in 1.28 hours and complete symptom resolution in 11.95 hours, and confirming its potentially differentiated profile for the treatment of HAE attacksFinal CHAPTER-1 data provide further evidence on long-term safety and efficacy of deucrictibant for the prevention of HAE attack...
- ING Helpdesk
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.